Moderna’s Cancer Vaccine Sent Stock Soaring
Moderna’s Cancer Breakthrough Just Sent the Stock Soaring 93%
The vaccine is individualized using Moderna’s messenger-RNA technology to flag dozens of mutations unique to each patient’s tumor.
The companies will confer with U.S. regulators about filing for approval of the combination treatment.
Source: Barron's